ESSA Pharma Files For Up to $200 Million in Securities - (Fidelity via NewsPoints Desk)

  • ESSA Pharma filed a registration statement on Wednesday covering the potential sale of up to $200 million in securities, as reported by Fidelity.

  • The securities include common shares, preferred shares, debt securities, subscription receipts, warrants and units.

  • Net proceeds will be used for general corporate purposes, including funding research and development, preclinical and clinical expenses, as well as corporate costs.

To read more NewsPoints articles, click here.